TLR4 and neurodegenerative disease: Therefore, modulating the expression of TLR4-dependent caspase3 signaling that governs the expression of proinflammatory mediators may be a potential therapeutic strategy for amelioration of microglia-mediated neuroinflammation that is widely implicated in major neurodegenerative diseases.